Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia

The Journal of ECT
Nagahisa OkamotoToru Nishikawa

Abstract

Reports of the superiority of the antidepressant effect of ketamine during the conduct of electroconvulsive therapy (ECT) have been limited. We conducted an open-label trial of ketamine to determine whether ketamine as the anesthetic during ECT would provide a greater antidepressant effect than the antidepressant effect obtained with propofol. Between April 2006 and April 2007, 31 inpatients with treatment-resistant depression gave written consent for ECT and to participate in this study. An anesthesiologist who was unaware of the mental symptoms of the subjects assigned them to receive propofol or ketamine anesthetic according to the preferences of the patients, and the patients underwent 8 ECT sessions for 4 weeks. The Hamilton Depression Rating Scale (HDRS) was valuated before ECT and after the completion of the second, fourth, sixth, and eighth ECT sessions. The HDRS scores improved earlier in the ketamine group, with decreases in HDRS scores that were significantly greater in the ketamine group. The results suggested that it is possible to improve symptoms of depression earlier by using ketamine anesthesia.

References

Jun 1, 1972·The British Journal of Psychiatry : the Journal of Mental Science·C L BrewerS Hereward
Aug 29, 1994·Neuroscience Letters·C A Stewart, I C Reid
Sep 25, 1998·Physiology & Behavior·G A MickleyB K Yamamoto
Feb 25, 2000·Biological Psychiatry·R M BermanJ H Krystal
Jun 1, 2000·The American Journal of Psychiatry·A D KrystalR W Massie
Jan 29, 2002·Pharmacology, Biochemistry, and Behavior·A YilmazR Canbeyli
Jan 31, 2003·The Journal of Neuropsychiatry and Clinical Neurosciences·Andrew D KrystalC Edward Coffey
Oct 30, 2004·The American Journal of Psychiatry·Gerard SanacoraJohn H Krystal
Jul 5, 2005·The American Journal of Psychiatry·Robert OstroffGerard Sanacora
Aug 9, 2006·Archives of General Psychiatry·Carlos A ZarateHusseini K Manji
Jun 2, 2009·Brain Research Reviews·Kenji Hashimoto

❮ Previous
Next ❯

Citations

Apr 6, 2013·Der Anaesthesist·U Grundmann, S O Schneider
May 25, 2012·Journal of Anesthesia·Saban YalcinTekin Bilgiç
Dec 10, 2013·Journal of Neural Transmission·Mark J NiciuCarlos A Zarate
Jan 18, 2014·L'Encéphale·P De MaricourtR Gaillard
Feb 2, 2013·CNS Spectrums·Mario Catena-Dell'OssoDonatella Marazziti
Sep 9, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xiaohua LiRichard C Shelton
Aug 1, 2012·The Journal of ECT·Chadi G AbdallahRobert Ostroff
Nov 16, 2012·Medical Devices : Evidence and Research·Khalid Saad Al-Harbi, Naseem Akhtar Qureshi
Jan 7, 2014·Psychiatry Research·Keith G RasmussenJohn P Abenstein
Feb 16, 2013·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Jul 2, 2011·Depression and Anxiety·A John Rush
Jan 15, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Keith G Rasmussen
Aug 4, 2012·Journal of Affective Disorders·Colleen K LooRoss Mac-Pherson
Dec 4, 2014·Psychiatry Research·Arpan DuttaJ F William Deakin
May 11, 2013·The Australian and New Zealand Journal of Psychiatry·Natalie KatalinicColleen K Loo
Jul 9, 2016·Revista de psiquiatrí́a y salud mental·Susana AlberichAna González-Pinto
Mar 4, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Gordon FernieIan C Reid
Dec 3, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Dian-Jeng LiPao-Yen Lin
Nov 29, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Verònica GálvezColleen K Loo
Jun 30, 2016·Therapeutic Advances in Psychopharmacology·John MullerSrinivas Pentyala
May 31, 2018·Journal of Neurosurgical Anesthesiology·Charles William CarspeckenIrene Rozet
Jul 21, 2014·Psychopharmacology·Guillaume FondLaurent Boyer
Aug 3, 2014·Journal of Anesthesia·Feray ErdilMahmut Durmuş
Jan 20, 2016·Current Behavioral Neuroscience Reports·Sara CostiJames W Murrough
Nov 6, 2015·Current Opinion in Anaesthesiology·Ross D MacPherson
Apr 21, 2017·European Archives of Psychiatry and Clinical Neuroscience·Maxim ZavorotnyyCarsten Konrad
Apr 28, 2018·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Jonathan J GambleLloyd Balbuena
Mar 16, 2012·Anaesthesia and Intensive Care·G Erdogan KayhanM O Ersoy
Mar 15, 2011·European Archives of Psychiatry and Clinical Neuroscience·Laura KranasterAlexander Sartorius
May 26, 2018·Current Opinion in Anaesthesiology·Kathryn Cobb, Monika Nanda
Jul 24, 2020·European Archives of Psychiatry and Clinical Neuroscience·Alexander SartoriusChristoph Janke
Mar 3, 2015·Annals of the New York Academy of Sciences·Chadi G AbdallahJohn H Krystal
Apr 21, 2020·Anesthesiology Research and Practice·Abby PribishArun Kalava
Jul 23, 2020·Journal of Affective Disorders·Ravi K SharmaJagadisha Thirthalli
Apr 3, 2020·Journal of the Neurological Sciences·Molly C KalmoeCharles R Conway

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.